References:

［1］Cassone G,Manfredi A,Vacchi C,et al.Treatment of rheumatoid arthritis-associated interstitial lung disease:lights and shadows［J］.Journal of Clinical Medicine,2020,9(4):1082.
［2］陆国辉,李艳茹,高健美.甘草干姜汤对博莱霉素诱导的大鼠肺纤维化SIRT1和TGF-β1蛋白表达的影响［J］.中药药理与临床,2014,30(6):25-28.
［3］肖小花,李戎,梁繁荣,等.论中医“肺痿”一名与“肺纤维化”最为相侔［J］.辽宁中医杂志,2012,39(6):1045-1047.
［4］章懿婷,何焕荣.何焕荣教授治疗类风湿关节炎相关间质性肺病的经验［J］.风湿病与关节炎,2020,9(7):36-37,48.
［5］郑继生,钱景莉,蔡宛如.蔡宛如辨治间质性肺病临床经验述要［J］.浙江中医杂志,2020,55(9):641-642.
［6］杨睿,曲妮妮.从瘀探讨特发性肺间质纤维化中医病因病机［J］.亚太传统医药,2019,15(5):188-189.
［7］邓岳潼,吕晓东,庞立健,等.特发性肺间质纤维化肺虚络瘀病机理论与氧化应激发病机制［J］.辽宁中医药大学学报,2018,20(7):122-125.
［8］齐春华,王伟钢.类风湿关节炎合并间质性肺病血清学的研究进展［J］.风湿病与关节炎,2017,6(1):71-74.
［9］Leslie KO.Pathology of interstitial lung disease［J］.Clinics in Chest Medicine,2004,25(4):657-703,vi.
［10］Phillips RJ,Burdick MD,Hong K,et al.Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis［J］.The Journal of Clinical Investigation,2004,114(3):438-446.
［11］刘渡舟,傅士垣.伤寒论诠解［M］.天津:天津科学技术出版社,1983.
［12］Juge PA,Lee JS,Ebstein E,et al.MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease［J］.The New England Journal of Medicine,2018,379(23):2209-2219.
［13］Urakawa K,Mihara M,Suzuki T,et al.Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects［J］.Immunopharmacology,2000,48(2):137-144.
［14］王明新.甘草干姜汤的研究进展［J］.中国中医药现代远程教育,2017,15(21):152-154.
［15］李想,李冀.甘草提取物活性成分药理作用研究进展［J］.江苏中医药,2019,51(5):81-86.
［16］Hadjicharalambous MR,Lindsay MA.Idiopathic pulmonary fibrosis:pathogenesis and the emerging role of long non-coding RNAs［J］.International Journal of Molecular Sciences,2020,21(2):524.
［17］Mora AL,Woods CR,Garcia A,et al.Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice［J］.American Journal of Physiology Lung Cellular and Molecular Physiology,2005,289(5):L711-L721.
［18］杨晓露,刘朵,卞卡,等.甘草总黄酮及其成分体外抗炎活性及机制研究［J］.中国中药杂志,2013,38(1):99-104.
［19］方鉴.甘草及其有效成分对免疫系统调节作用探究［J］.海峡药学,2017,29(8):28-30.
［20］霍艳霞,李爱敏,王志华,等.氧化应激与特发性肺纤维化研究进展［J］.中国误诊学杂志,2011,11(34):8344-8345.
［21］陈千,熊富良,张雪琼,等.甘草苷对感染后咳嗽(肺阴虚证)小鼠的止咳作用机制及抗氧化作用的研究［J］.华中师范大学学报(自然科学版),2020,54(5):841-848,873.
［22］Ji YX,Huang JA,Zong JP,et al.The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance［J］.Zhonghua Jie He He Hu Xi Za Zhi,2008,31(4):264-267.
［23］付钰,吴瑕,陈随清.甘草查尔酮A通过调节TGF-β/Smad信号通路抑制小鼠肺纤维化［J］.中国实验方剂学杂志,2019,25(4):94-100.
［24］耿艳艳,于冰,周植星,等.甘草次酸衍生物TY501抗肺纤维化作用及机制研究［J］.中国药理学通报,2015,31(2):210-215.
［25］亓雪,张颖颖.干姜的化学、药理研究进展［J］.山东化工,2018,47(14):41-42.
［26］支开叶.肺纤方治疗特发性肺纤维化临床观察［J］.山西中医,2011,27(12):23-24,26.
［27］刘桂廷,史琦,阎玥,等.运用温润辛金培本系列疗法治疗间质性肺疾病经验［J］.湖北中医药大学学报,2020,22(4):114-117.
［28］陆国辉,李艳茹,高健美.甘草干姜汤对博莱霉素诱导的大鼠肺纤维化SIRT1和TGF-β1蛋白表达的影响［J］.中药药理与临床,2014,30(6):25-28.
［29］康荻.肺痿论治肺纤维化的实验研究［D］.北京:北京中医药大学,2017.
［30］黄煌,姚一中,刘金洪,等.新型冠状病毒肺炎(COVID-19)经方防治推荐方案(国际第1版)［J］.江苏中医药,2020,52(6):1-7.
［31］付钰,吴瑕,陈随清.甘草查尔酮A通过调节TGF-β/Smad信号通路抑制小鼠肺纤维化［J］.中国实验方剂学杂志,2019,25(4):94-100.
［32］亓雪,张颖颖.干姜的化学、药理研究进展［J］.山东化工,2018,47(14):41-42.
［33］陈志磊,张奉春.结缔组织病相关间质性肺疾病:必须重视的疾病［J］.协和医学杂志,2018,9(3):193-196.